Stock screenerAll disclosures →
EDGAR →
BEAM
Conviction 100HealthcareScan · Thu, Jun 25, 2026BEAM$33.96+0.18%
ResistanceSupportVol 14Vol MA14 2.46M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price33.96
Change+0.18%
Gap+1.67%
Rel volume2.32×
Avg volume2.35M
Avg $ vol75.64M
SMA 2031.56
SMA 5030.61
SMA 20027.29
Price vs 50+10.95%
Price vs 200+24.45%
MA stackbullish
50/200 cross—
Supertrendup · 29.21
RSI (14)59
MACD hist0.36
MACD crossbull · 5d
Stoch %K / %D65 / 62
ADX (14)23
+DI / −DI29 / 16
RSI divergence—
MACD divergence—
ATR %+6.81%
ADR %6.97%
52w high35.53
52w low16.01
From 52w high-4.42%
Above 52w low+112.12%
New 52w highNo
SqueezeOff
Bollinger width25.04%
%B0.80
Donchian pos65.97%
Donchian high36.88
Donchian low28.30
AVWAP (52w high)34.55
vs AVWAP high-1.72%
AVWAP (52w low)26.71
vs AVWAP low+27.15%
OBV trendUp
Chaikin MF (20)-0.08
Today vs 20d2.32×
Avg vol (14d)2.46M
Avg vol (20d)2.35M
Avg $ vol (20d)75.64M
Market cap3.49B
RS 3m (vs SPY)+29.29%
RS 6m (vs SPY)+19.85%
RS line new highNo
Trend template8/8
Technical rank81.0
1 week+4.56%
1 month+14.00%
3 months+46.89%
6 months+21.63%
1 year+98.02%
YTD+25.13%
P/E-43.68
P/B3.00
P/S25.00
P/FCF-9.70
EPS-0.8100
Div yield—
ROE-6.87%
ROA-5.40%
Debt/Eq0.09
Current16.99
EV/EBITDA-9.15
Gross margin—
Net margin-57.24%
Rev growth120.01%
EPS growth78.77%
Price target52.91
Target upside55.80%
Analyst ratingBuy
Institutional117.85%
Ent. value3.31B
Revenue31.74M
Net income-94.32M
Gross profit—
Free cash flow-360.05M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out102.88M
Employees522
ListedThu, Feb 6, 2020
Free float79.74M
Float %78.3%
Short interest21.46M
Days to cover11.7d
Short volume49.6%
Squeeze score86 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$1.00 · 5 est
Last EPS vs est−$0.91 vs −$0.87
Last surprise-4.6% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank81.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance35.63
Support27.09
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BEAM
No recent disclosed trades by Congress in BEAM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BEAM · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ciaramella Giuseppe President · Common Stock · 2026-06-17 | Exercise | 6.5K | $4K | 2026-06-17 | 2026-06-22 |
Ciaramella Giuseppe President · Common Stock · 2026-06-17 | Exercise | 29K | $30K | 2026-06-17 | 2026-06-22 |
Ciaramella Giuseppe President · Stock Option (Right to Buy) · 2026-06-17 | Exercise | 6.5K | — | 2026-06-17 | 2026-06-22 |
Ciaramella Giuseppe President · Stock Option (Right to Buy) · 2026-06-17 | Exercise | 29K | — | 2026-06-17 | 2026-06-22 |
Shaw Christi Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
Fishman Mark Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
MARAGANORE JOHN Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
COOPER GRAHAM K Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
Guindo Chirfi Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
Walsh Kathleen E Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 19.68K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in BEAM · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.